Status | Study |
Not yet recruiting |
Study Name: Tamoxifen Citrate or Afimoxifene in Treating Patients With Estrogen Receptor Positive Breast Cancer Condition: Ductal Breast Carcinoma In Situ Estrogen Receptor Positive Date: 2016-12-14 Interventions: Drug: Afimoxifene Applied to t |
Not yet recruiting |
Study Name: Comparative Effectiveness of Sentinel Lymph Node Biopsy for Ductal Carcinoma In Situ Condition: Ductal Carcinoma In Situ Date: 2016-08-30 Interventions: Procedure: Sentinel lymph node biopsy (SLNB) Intervention is defined as that the DCIS patient has underg |
Active, not recruiting |
Study Name: Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS) Condition: Carcinoma, Intraductal, Noninfiltrating Date: 2016-08-10 Interventions: Drug: Pembrolizumab Other Names: Keytruda MK-3475 |
Recruiting |
Study Name: Conjugated Estrogens/Bazedoxifene in Treating Patients With Ductal Carcinoma in Situ Undergoing Surgery Condition: Ductal Breast Carcinoma In Situ Postmenopausal Date: 2016-02-24 Interventions: Drug: Conjugated Estrogens/Bazedoxifene |
Recruiting |
Study Name: Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Condition: Ductal Breast Carcinoma In Situ Date: 2015-12-18 Interventions: Other: Laboratory Biomarker Analysis |
Recruiting |
Study Name: Women Informed to Screen Depending on Measures of Risk Condition: Breast Neoplasms Carcinoma, Intraductal, Noninfiltrating Date: 2015-12-01 Interventions: Other: Complete a health questionnaire |
Recruiting |
Study Name: MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Condition: Ductal Breast Carcinoma In Situ Date: 2015-01-16 Interventions: Procedure: Magnetic Resonance Imaging |
Active, not recruiting |
Study Name: Effects of Diet and Exercise on Ductal Carcinoma in Situ Condition: Ductal Carcinoma In Situ Breast Cancer Date: 2014-08-19 Interventions: Behavioral: Active Comparator: Progressive Resistance Training (PRT) and a h |
Recruiting |
Study Name: Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast Cancer Condition: Breast Cancer Ductal Carcinoma in Situ Date: 2014-04-28 Interventions: Drug: Intranasal Oxytocin Intranasal spray, one spray or 4 IU of oxytocin will be administered into each |
Completed |
Study Name: Management of Ductal Carcinoma in Situ or Pure Micro-invasive Extended Breast Condition: Intraductal Carcinoma and Lobular Carcinoma in Situ Date: 2012-11-05 Interventions: Procedure: sentinel node biopsy and mastectomy sentinel node biopsy and mastectomy |